Gron Ventures
VC Fund
Newport Beach, United States
Gron Ventures is a venture capital firm that invests in the cannabis, e-commerce, food-tech, consumer products, and services sectors.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 36%
Last updated:
For AI agents: llms.txt
Industries Gron Ventures invests in
Stages Gron Ventures invests in
Countries Gron Ventures invests in
Round sizes
Round size
- Series A
- $4.5M–$27M
- Series B
- $10M–$39M
- Series C
- $1.4M–$200M
Investment Focus
Industry
- Cannabis 3 (27%)
- Health Care 2 (18%)
- Sales 1 (9%)
- Retail 1 (9%)
- Medical 1 (9%)
Stage
- Series A 3 (27%)
- Series B 3 (27%)
- Series C 2 (18%)
- Convertible Note 2 (18%)
- Series D 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lucid Green
|
Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $1.4M / Series C / Jul 10, 2024 | |
Heading Health
|
Heading Health is a technology-enabled mental health platform improving access to high-quality and affordable care. Heading delivers personalized treatment solutions that leverage evidence-based therapeutics and technologies such as Spravato, transcranial magnetic stimulation, telepsychiatry, and intramuscular ketamine. | $4.5M / Series A / Jun 29, 2023 | |
Gilgamesh Pharmaceuticals
|
Gilgamesh Pharmaceuticals focuses on developing therapeutics that target neuropsychiatric and central nervous system conditions using small molecules derived from research on psychedelic compounds. The company designs and tests compounds that aim to modulate brain pathways involved in mental health disorders while reducing hallucinogenic effects.Its pipeline includes drug candidates intended for conditions such as depression, anxiety, and substance use disorders. Gilgamesh Pharmaceuticals conducts preclinical and clinical studies to evaluate the safety, dosing, and efficacy of its compounds. The company integrates medicinal chemistry, neuroscience, and clinical research to support drug development and regulatory progression. | $39M / Series B / Dec 15, 2022 | |
|
Lucid Green
|
Lucid Green enables the cannabis industry to communicate trust and transparency through a direct connection with the consumer. It gives brands a direct-to-consumer and direct-to-budtender marketing channel while incentivizing brands and their suppliers to provide accurate and timely product information. As a blockchain solution, all actions bydata uploaders and data consumers are governed and driven by a sophisticated, immutable ledger and a token economy. It was founded in 2018 and is headquartered in New York, New York. | $10M / Series B / Mar 27, 2022 | |
Dutchie
|
Dutchie is an all-in-one technology platform that powers dispensary operations, provides consumers with safe and easy access, and supports the wave of positive societal change that cannabis is bringing to the world. The company was founded in 2017 and is headquartered in Bend, Oregon. | $350M / Series D / Oct 14, 2021 | |
Pure Beauty
|
Pure Beauty is an e-commerce platform that offers products in different categories. | $5M / Convertible Note / Jul 15, 2021 | |
Pure Beauty
|
Pure Beauty is a cannabis brand located in Los Angeles. | $5M / Convertible Note / Jul 15, 2021 | |
|
Gilgamesh Pharmaceuticals
|
Gilgamesh Pharmaceuticals focuses on developing therapeutics that target neuropsychiatric and central nervous system conditions using small molecules derived from research on psychedelic compounds. The company designs and tests compounds that aim to modulate brain pathways involved in mental health disorders while reducing hallucinogenic effects.Its pipeline includes drug candidates intended for conditions such as depression, anxiety, and substance use disorders. Gilgamesh Pharmaceuticals conducts preclinical and clinical studies to evaluate the safety, dosing, and efficacy of its compounds. The company integrates medicinal chemistry, neuroscience, and clinical research to support drug development and regulatory progression. | $27M / Series A / May 06, 2021 | |
|
Dutchie
|
Dutchie is an all-in-one technology platform that powers dispensary operations, provides consumers with safe and easy access, and supports the wave of positive societal change that cannabis is bringing to the world. The company was founded in 2017 and is headquartered in Bend, Oregon. | $200M / Series C / Mar 16, 2021 | |
|
Dutchie
|
Dutchie is an all-in-one technology platform that powers dispensary operations, provides consumers with safe and easy access, and supports the wave of positive societal change that cannabis is bringing to the world. The company was founded in 2017 and is headquartered in Bend, Oregon. | $35M / Series B / Aug 18, 2020 | |
| See all 11 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Gron Ventures invest in?
Gron Ventures invests primarily in Cannabis, Health Care and Sales startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Gron Ventures's check size?
Gron Ventures typically joins rounds of $4.5M–$27M at Series A, $10M–$39M at Series B and $1.4M–$200M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Gron Ventures participates in.
When did Gron Ventures last invest?
The most recent investment recorded for Gron Ventures closed in Jul 2024. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
